{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:11:24Z","timestamp":1753891884834,"version":"3.41.2"},"reference-count":18,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Mol. Neurosci."],"DOI":"10.3389\/fnmol.2023.1258458","type":"journal-article","created":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T15:55:39Z","timestamp":1690905339000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Editorial: Gene therapy for the central and peripheral nervous system, volume II"],"prefix":"10.3389","volume":"16","author":[{"given":"Andrew P.","family":"Tosolini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George M.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,8,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"eabn4704","DOI":"10.1126\/sciadv.abn4704","article-title":"Semirational bioengineering of AAV vectors with increased potency and specificity for systemic gene therapy of muscle disorders","volume":"8","author":"Andari","year":"2022","journal-title":"Sci. Adv."},{"key":"B2","doi-asserted-by":"publisher","first-page":"eadf4888","DOI":"10.1126\/sciadv.adf4888","article-title":"BBB opening with focused ultrasound in nonhuman primates and Parkinson's disease patients: targeted AAV vector delivery and PET imaging","volume":"9","author":"Blesa","year":"2023","journal-title":"Sci. Adv."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41591-019-0674-1","article-title":"Spinal subpial delivery of AAV9 enables widespread gene silencing and blocks motoneuron degeneration in ALS","volume":"5","author":"Bravo-Hernandez","year":"2020","journal-title":"Nat. Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1146\/annurev-neuro-111020-100834","article-title":"Adeno-associated virus toolkit to target diverse brain cells","volume":"45","author":"Challis","year":"2022","journal-title":"Annu. Rev. Neurosci."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1038\/nn.4593","article-title":"Engineered AAVs for efficient noninvasive gene delivery to the central and peripheral nervous systems","volume":"20","author":"Chan","year":"2017","journal-title":"Nat. Neurosci."},{"key":"B6","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1080\/14712598.2017.1250880","article-title":"Translational development of splice-modifying antisense oligomers","volume":"17","author":"Fletcher","year":"2016","journal-title":"Exp. Opin. Biol. Ther."},{"key":"B7","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/s41593-021-00969-4","article-title":"AAV capsid variants with brain-wide transgene expression and decreased liver targeting after intravenous delivery in mouse and marmoset","volume":"25","author":"Goertsen","year":"2022","journal-title":"Nat. Neurosci."},{"key":"B8","doi-asserted-by":"publisher","first-page":"e65646","DOI":"10.1371\/journal.pone.0065646","article-title":"Glial promoter selectivity following aav-delivery to the immature brain","volume":"8","author":"Jonquieres","year":"2013","journal-title":"PLoS ONE"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1056\/NEJMoa1706198","article-title":"Single-dose gene-replacement therapy for spinal muscular atrophy","volume":"377","author":"Mendell","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1056\/NEJMoa1710504","article-title":"Nusinersen versus sham control in later-onset spinal muscular atrophy","volume":"378","author":"Mercuri","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/s41434-020-0169-1","article-title":"Optimization of adeno-associated viral vector-mediated transduction of the corticospinal tract: comparison of four promoters","volume":"28","author":"Nieuwenhuis","year":"2021","journal-title":"Gene Ther."},{"key":"B12","doi-asserted-by":"publisher","first-page":"e157191","DOI":"10.1172\/jci.insight.157191","article-title":"Boosting peripheral BDNF rescues impaired in vivo axonal transport in CMT2D mice","volume":"8","author":"Sleigh","year":"2023","journal-title":"JCI Insight"},{"key":"B13","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1038\/nbt1117-998","article-title":"First AAV gene therapy poised for landmark approval","volume":"35","author":"Smalley","year":"2017","journal-title":"Nat. Biotechnol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"610","DOI":"10.3389\/fnmol.2017.00405","article-title":"Motor neuron gene therapy: lessons from spinal muscular atrophy for amyotrophic lateral sclerosis","volume":"10","author":"Tosolini","year":"2017","journal-title":"Front. Mol. Neurosci."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.3389\/fnmol.2020.00129","article-title":"Intramuscular delivery of gene therapy for targeting the nervous system","volume":"13","author":"Tosolini","year":"2020","journal-title":"Front. Mol. Neurosci."},{"key":"B16","doi-asserted-by":"publisher","first-page":"54","DOI":"10.3389\/fnmol.2018.00054","article-title":"Editorial: gene therapy for the central and peripheral nervous system","volume":"11","author":"Tosolini","year":"2018","journal-title":"Front. Mol. Neurosci."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1038\/gt.2008.104","article-title":"Construction and analysis of compact muscle-specific promoters for AAV vectors","volume":"15","author":"Wang","year":"2008","journal-title":"Gene Ther."},{"key":"B18","doi-asserted-by":"publisher","first-page":"e10258","DOI":"10.1002\/btm2.10258","article-title":"Viral vector-based gene therapies in the clinic","volume":"7","author":"Zhao","year":"2022","journal-title":"Bioen. Transl. Med."}],"container-title":["Frontiers in Molecular Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnmol.2023.1258458\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T15:55:48Z","timestamp":1690905348000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnmol.2023.1258458\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,1]]},"references-count":18,"alternative-id":["10.3389\/fnmol.2023.1258458"],"URL":"https:\/\/doi.org\/10.3389\/fnmol.2023.1258458","relation":{},"ISSN":["1662-5099"],"issn-type":[{"type":"electronic","value":"1662-5099"}],"subject":[],"published":{"date-parts":[[2023,8,1]]},"article-number":"1258458"}}